Integrated Diagnostics for Early Diagnosis of Liver Disease

Abroad (travel likely)Recruiting

Conditions

Non-Alcoholic Fatty Liver Disease · Non-alcoholic Steatohepatitis · Alcoholic Liver Disease · Liver Fibroses

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Manchester University NHS Foundation Trust, Manchester, Greater Manchester, United Kingdom
Contact: Study coordinator (Varinder Athwal) · Varinder.athwal@manchester.ac.uk

Study leads

Varinder Athwal
Principal Investigator
Manchester University NHS Foundation Trust/Manchester University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Longitudinal Observational Study Of Chinese With NAFLD/NASH

Non-Alcoholic Fatty Liver Disease (NAFLD) · Non-Alcoholic Steatohepatitis (NASH)

Abroad (travel likely)Recruiting

Hong Kong, Hong Kong

NAC- NAFLD And Cushing

Cushing Syndrome · Fatty Liver Disease

Abroad (travel likely)Recruiting

Angers, France · Bordeaux, France

A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH

Non-alcoholic Fatty Liver Disease

Abroad (travel likely)RecruitingPHASE3

Arcadia, United States · Covina, United States

Liver-gut Axis Study Through Identification of Liver Disease-specific Microbiome

Autoimmune Hepatitis · Primary Sclerosing Cholangitis · Non-Alcoholic Fatty Liver Disease

Abroad (travel likely)Recruiting

Daejeon, South Korea